{"id":"W3167481271","doi":"10.1200/jco.2021.39.15_suppl.e19537","title":"Safety and efficacy of tisagenlecleucel (tisa-cel) plus pembrolizumab (pembro) in patients (pts) with relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL): Updated analysis of the phase 1b PORTIA study.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Internal medicine; Refractory (planetary science); Neutropenia; Phases of clinical research; Surgery; Gastroenterology; Clinical trial; Oncology; Toxicity","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002332231,0.0004644996,0.0007773515,0.0004338473,0.0001508659,0.001052013,0.0006341702,0.0004938043,0.001475157],"category_scores_gemma":[0.001556357,0.0002894712,0.001071957,0.0004885172,0.0003146737,0.0006374974,0.0003350133,0.001433394,0.0003109044],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008495289,"about_ca_system_score_gemma":0.0007185107,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005773685,"about_ca_topic_score_gemma":0.002103382,"domain_scores_codex":[0.9994393,0.0002888676,0.00004680316,0.00006617692,0.0001084602,0.00005041682],"domain_scores_gemma":[0.9990049,0.000243946,0.0003955483,0.00007239448,0.00007074984,0.0002125829],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3914354,0.01188187,0.1875318,0.001981985,0.008663439,0.0006519165,0.0003368624,0.00419255,0.04354563,0.0002884387,0.01016664,0.3393234],"study_design_scores_gemma":[0.1473914,0.2355975,0.5641279,0.0002945741,0.01106991,0.002460914,0.0001601897,0.004805549,0.01076477,0.0004280787,0.02279872,0.0001006178],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9869952,0.007701804,0.0004148091,0.0003820021,0.00004454568,0.0003773839,0.002111703,0.00006687194,0.001905756],"genre_scores_gemma":[0.9907026,0.002243931,0.0007007561,0.0006152511,0.00009558527,0.000230485,0.004627651,0.00001690501,0.0007670057],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002332231,"threshold_uncertainty_score":0.01233411,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04626106429265371,"score_gpt":0.4152705730423476,"score_spread":0.3690095087496939,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}